Elevance Health Inc. (ELV) Reports In-Line Q4 EPS, Beats on Revenue; Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SPY
9. SWKS
10. FISV

Go back to Elevance Health Inc. (ELV) Reports In-Line Q4 EPS, Beats on Revenue; Offers Guidance

Elevance Health Reports Results for Fourth Quarter and Full Year 2023; Sets Full Year 2024 Outlook

January 24, 2024 6:00 AM EST

4Q 2023 operating revenue of $42.5 billion, up 7.0% from 4Q 2022; FY 2023 operating revenue of $170 billion, up 9.3% from FY 2022 4Q 2023 GAAP diluted EPS1 of $3.63, up 1.1% from 4Q 2022 and adjusted diluted EPS2 of $5.62, up 15.2%; FY 2023 GAAP diluted EPS of $25.22, up 3.9% from FY 2022 and adjusted diluted EPS2 of $33.14, up 16.2% Projected FY 2024 GAAP diluted EPS and adjusted diluted EPS2 of greater than $34.29 and $37.10 per share, respectively Quarterly dividend increased by 10.1% to $1.63 per share

INDIANAPOLIS--(BUSINESS WIRE)-- Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full... More